Dimopoulos, M A <br/><br/>
The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal function.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Mar 2012 
 - 722-729 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdr276  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--blood<br/>Neoplasm Staging--methods<br/>Prognosis<br/>Renal Insufficiency--blood<br/>Young Adult<br/>beta 2-Microglobulin--blood